221 related articles for article (PubMed ID: 22137640)
1. Cardiovascular biology of microsomal prostaglandin E synthase-1.
Wang M; FitzGerald GA
Trends Cardiovasc Med; 2010 Aug; 20(6):189-95. PubMed ID: 22137640
[TBL] [Abstract][Full Text] [Related]
2. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
Wang M; Song WL; Cheng Y; Fitzgerald GA
J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
Koeberle A; Werz O
Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
[TBL] [Abstract][Full Text] [Related]
4. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.
Koeberle A; Pollastro F; Northoff H; Werz O
Br J Pharmacol; 2009 Mar; 156(6):952-61. PubMed ID: 19298395
[TBL] [Abstract][Full Text] [Related]
5. Membrane prostaglandin E synthase-1: a novel therapeutic target.
Samuelsson B; Morgenstern R; Jakobsson PJ
Pharmacol Rev; 2007 Sep; 59(3):207-24. PubMed ID: 17878511
[TBL] [Abstract][Full Text] [Related]
6. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
[TBL] [Abstract][Full Text] [Related]
7. PGE synthase inhibitors as an alternative to COX-2 inhibitors.
Jachak SM
Curr Opin Investig Drugs; 2007 May; 8(5):411-5. PubMed ID: 17520870
[TBL] [Abstract][Full Text] [Related]
8. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.
Wang M; Zukas AM; Hui Y; Ricciotti E; Puré E; FitzGerald GA
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14507-12. PubMed ID: 16973753
[TBL] [Abstract][Full Text] [Related]
9. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
[TBL] [Abstract][Full Text] [Related]
10. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
Korotkova M; Jakobsson PJ
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
[TBL] [Abstract][Full Text] [Related]
11. Deletion of microsomal prostaglandin E synthase-1 does not alter ozone-induced airway hyper-responsiveness.
Wang M; Cooper PR; Jiang M; Zhao H; Hui Y; Yao Y; Tate JC; Damera G; Lawson JA; Jester WF; Haczku A; Panettieri RA; FitzGerald GA
J Pharmacol Exp Ther; 2010 Jul; 334(1):63-8. PubMed ID: 20371706
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E(2) synthase inhibition as a therapeutic target.
Iyer JP; Srivastava PK; Dev R; Dastidar SG; Ray A
Expert Opin Ther Targets; 2009 Jul; 13(7):849-65. PubMed ID: 19530988
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function.
Cheng Y; Wang M; Yu Y; Lawson J; Funk CD; Fitzgerald GA
J Clin Invest; 2006 May; 116(5):1391-9. PubMed ID: 16614756
[TBL] [Abstract][Full Text] [Related]
14. Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice.
Isono M; Suzuki T; Hosono K; Hayashi I; Sakagami H; Uematsu S; Akira S; DeClerck YA; Okamoto H; Majima M
Life Sci; 2011 Apr; 88(15-16):693-700. PubMed ID: 21324324
[TBL] [Abstract][Full Text] [Related]
15. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
Timmers L; Pasterkamp G; de Kleijn DP
Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439
[TBL] [Abstract][Full Text] [Related]
16. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template.
Wang J; Limburg D; Carter J; Mbalaviele G; Gierse J; Vazquez M
Bioorg Med Chem Lett; 2010 Mar; 20(5):1604-9. PubMed ID: 20144869
[TBL] [Abstract][Full Text] [Related]
17. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2.
Caughey GE; Cleland LG; Penglis PS; Gamble JR; James MJ
J Immunol; 2001 Sep; 167(5):2831-8. PubMed ID: 11509629
[TBL] [Abstract][Full Text] [Related]
18. Relationship of the Topological Distances and Activities between mPGES-1 and COX-2 versus COX-1: Implications of the Different Post-Translational Endoplasmic Reticulum Organizations of COX-1 and COX-2.
Akasaka H; So SP; Ruan KH
Biochemistry; 2015 Jun; 54(23):3707-15. PubMed ID: 25988363
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
[TBL] [Abstract][Full Text] [Related]
20. Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol.
Rörsch F; Wobst I; Zettl H; Schubert-Zsilavecz M; Grösch S; Geisslinger G; Schneider G; Proschak E
J Med Chem; 2010 Jan; 53(2):911-5. PubMed ID: 20025212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
